Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model

Смертность при легочной артериальной гипертензии: прогнозирование с помощью модели стратификации риска, предложенной рекомендациями Европейского общества по легочной гипертензии 2015 года
Stephan Rosenkranz, Marion Delcroix, Anton Vonk Noordegraaf, Carmine Dario Vizza, Hossein Ardeschir Ghofrani, Marius M. Hoeper, J. Simon R. Gibbs, Christian F. Opitz, Oliver Distler, Karen M. Olsson, Ekkehard Grünig, Dörte Huscher, David Pittrow, Tilmann Kramer, Zixuan Pan, Christina A. Eichstaedt, Jens Spießhoefer, Nicola Benjamin, Katrin Meyer
2017-08-01

1-year mortalityCOMPERA registryEuropean PH guidelinespulmonary arterial hypertensionrisk stratification
The 2015 European pulmonary hypertension (PH) guidelines propose a risk stratification strategy for patients with pulmonary arterial hypertension (PAH). Low-, intermediate- and high-risk strata are defined by estimated 1-year mortality risks of <5%, 5-10% and >10%, respectively. This risk assessment strategy awaits validation.We analysed data from patients with newly diagnosed PAH enrolled into COMPERA (Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension), a European-based PH registry. An abbreviated version of the risk assessment strategy proposed by the European PH guidelines was applied, using the following variables: World Health Organization functional class, 6-min walking distance, brain natriuretic peptide or its N-terminal fragment, right atrial pressure, cardiac index and mixed venous oxygen saturation.Data from 1588 patients were analysed. Mortality rates were significantly different between the three risk strata (p<0.001 for all comparisons). In the entire patient population, the observed mortality rates 1 year after diagnosis were 2.8% in the low-risk cohort (n=196), 9.9% in the intermediate-risk cohort (n=1116) and 21.2% in the high-risk cohort (n=276). In addition, the risk assessment strategy proved valid at follow-up and in major PAH subgroups.An abbreviated version of the risk assessment strategy proposed by the current European PH guidelines provides accurate mortality estimates in patients with PAH.
1
Mortality differed significantly across low-, intermediate-, and high-risk strata, with all pairwise comparisons showing p<0.001.
2
Observed 1-year mortality was 2.8% for low-risk patients, 9.9% for intermediate-risk patients, and 21.2% for high-risk patients.
3
The abbreviated 2015 European pulmonary hypertension guideline risk model was evaluated in 1,588 newly diagnosed PAH patients from the COMPERA registry.
4
The abbreviated guideline-based model provided accurate mortality estimates in patients with pulmonary arterial hypertension.
5
The risk assessment strategy remained valid during follow-up and across major pulmonary arterial hypertension subgroups.

Patients with newly diagnosed pulmonary arterial hypertension (PAH) enrolled in the COMPERA European pulmonary hypertension registry

Validation and accuracy of the 2015 European pulmonary hypertension guidelines risk stratification model for estimating 1-year mortality across risk strata and PAH subgroups

Publication Details
Publication Date
2017-08-01
Journal
Publisher
ISSN
Cited by
692
Access Type
Author Information
Authors
Stephan Rosenkranz
Marion Delcroix
Anton Vonk Noordegraaf
Carmine Dario Vizza
Hossein Ardeschir Ghofrani
Marius M. Hoeper
J. Simon R. Gibbs
Christian F. Opitz
Oliver Distler
Karen M. Olsson
Ekkehard Grünig
Dörte Huscher
David Pittrow
Tilmann Kramer
Zixuan Pan
Christina A. Eichstaedt
Jens Spießhoefer
Nicola Benjamin
Katrin Meyer
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%